Ascending Single Dose Study of Rhu-pGelsolin in Patients With Decreased Gelsolin Levels
Phase 1
Completed
- Conditions
- Low GelsolinTraumaInfectionBurns
- Interventions
- Drug: PlaceboDrug: rhu-pGelsolin
- First Posted Date
- 2008-05-05
- Last Posted Date
- 2010-09-29
- Lead Sponsor
- Critical Biologics Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT00671307
- Locations
- ðŸ‡ðŸ‡°
Queen Mary Hospital; University of Hong Kong, Hong Kong, SAR, Hong Kong
© Copyright 2025. All Rights Reserved by MedPath